HYPR Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)$-0.430.0% YoY
Profit margin-262.3%HEALTHCARE
Market cap$184.2MMicro cap

Wall Street coverage

$2.03median target· current $0.83 (+145.8%)2 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E
PEG ratio
P/B
4.49
P/S (TTM)
13.58
EV/EBITDA
-0.72

Profitability & growth

ROE (TTM)
-79.0%
Operating margin
-144.9%
Revenue growth YoY
128.0%
Dividend yield
Beta
1.42
Last earnings
Mar 25, 2026 · Estimate $-0.08 · Reported $-0.08
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Hyperfine Inc

Hyperfine Inc. is an innovative leader in medical technology, renowned for developing the first FDA-cleared portable MRI system that revolutionizes access to imaging at the point of care. By delivering high-quality imaging directly at the bedside, Hyperfine enhances patient care and streamlines clinical decision-making, addressing the growing demand for efficient and accessible diagnostic solutions. The company's focus on cost efficiency and patient convenience uniquely positions it within the evolving healthcare landscape, making it a compelling opportunity for institutional investors…

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
351 NEW WHITFIELD STREET, GUILFORD, CT
Fiscal year end
December
Latest quarter
Dec 31, 2025
Market cap$184.2M
Shares outstanding$83.5M
52W high$2.22
52W low$0.53

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer